Recent advances in sialic acid-based active targeting chemoimmunotherapy promoting tumor shedding: a systematic review

Sialic acid-based active targeting chemoimmunotherapy utilizes the recognition between SA-modified preparations and SA-binding receptors on tumor-associated immune cells to deliver drugs, like a “Trojan horse”.